DLBCL Interim Response Evaluation for Customised Therapy

NCT04226937 · clinicaltrials.gov ↗

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

High-grade B-cell Lymphoma

Interventions

OTHER: Not Applicable as this is a translational, sample collection study.

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]
[object Object]